At ISC, the Fight Against COVID-19 Took the Stage – and Yes, Fugaku Was There

By Oliver Peckham

June 23, 2020

With over nine million infected and nearly half a million dead, the COVID-19 pandemic has seized the world’s attention for several months. It has also dominated the supercomputing sector, with COVID-related research receiving major allocations on nearly every research supercomputer in the world (and many industrial supercomputers). It’s not surprising, then, that at ISC 2020, the virtual conference opened, revealed the new Top500 list – and then got straight to COVID-19.

In the focus session, three speakers addressed how HPC is fighting back against the coronavirus: Satoshi Matsuoka of RIKEN, which just nabbed the top spot in the Top500 with its Fugaku system; Peter Coveney of the Centre of Excellence in Computational Biomedicine, which is working to make HPC and machine learning actionable in a rapid drug development workflow; and Rick Stevens of Argonne National Laboratory, where researchers are working with the COVID-19 HPC Consortium to comb through billions of molecules.

Satoshi Matsuoka highlights Fugaku’s role in COVID-19 research

Satoshi Matsuoka

Fugaku, the most powerful supercomputer in the world, is in business early thanks to COVID-19. The system – situated at Riken in Japan – was scheduled to launch in 2021. When the pandemic struck, plans changed. “It was decided by [Japan’s] Ministry of Education, Culture, Sports, Science and Technology that we will utilize [not only supercomputers that are already available] but also [deploy Fugaku early], almost a year ahead of schedule, to combat COVID-19,” explained Matsuoka, director of the Riken Center for Computational Science (R-CCS).

The Fugaku supercomputer

Fugaku’s showstopping 415 Linpack petaflops are close to triple the performance of the runner-up, Oak Ridge’s newly dethroned Summit system. At 158,976 nodes, Fugaku is the largest system ever created in terms of nodes, footprint and power consumption. The software, Matsuoka said, is “quite standard,” allowing for broad usability without much Fugaku-specific tweaking.

“They’re largely divided into two areas,” Matsuoka said of Fugaku’s COVID-19 workloads. “One is medical-pharma – so trying to see how the virus behaves, what are the effective drugs, especially how we can repurpose existing drugs and so forth and also how a vaccine is made. So these are molecular-level investigations of the virus and its countermeasures. The other is more macroscopic – so we’re trying to see how these viruses are transmitted and what are the mitigation measures and how it will impact society.”

Matsuoka highlighted several of the COVID-19 projects taking advantage of Fugaku’s early arrival. One Riken researcher, for instance, is studying conformational changes of the spike protein using a highly scalable molecular dynamics code. Another researcher is using fragment molecular orbital calculations to investigate the energy levels of the spike protein, scaling across hundreds of thousands of Fugaku’s CPUs. “On [Fugaku’s predecessor] the K computer,” Matsuoka said, “this calculation would have taken days, weeks, multiple weeks – on Fugaku, … they have been able to do this in just three hours.”

Other researchers are using Fugaku to run socially oriented simulations, such as simulating droplets in indoor spaces like trains or simulating the spread effects of using face masks or contact tracing applications, Matsuoka said – and, of course, there are more to come. “So if you have any good ideas,” he said, “go to the website and you can apply.” 

A Riken-led simulation of virus droplets in train cabins. Image courtesy of Satoshi Matsuoka.

Peter Coveney describes a new, HPC- and AI-driven model for drug development

Peter Coveney

Coveney, the second speaker, runs the Centre of Excellence in Computational Biomedicine (CompBioMed), an initiative funded by the European Union that is currently redirecting its research efforts and computational research to the study of and drug development for COVID-19. Coveney (who also teaches at University College London) stressed the need to “invert the model [of drug development] as it currently exists” using advanced IT.

“The opportunities there are enormous,” Coveney said. “What we’re really trying to do is transform the approach to biomedicine, to be able to move it from a highly empirical approach … to putting a priority on the predictions that come out of computers.”

But to do that, he said, the computational results had to be actionably accurate – and perhaps even more difficult, they had to be quickly produced. Molecular screening, however – the crux of computational drug design, whereby compounds are fitted to targets on the virus’ proteins – is labor-intensive, time-consuming and expensive ($1 to $10 a compound, with billions of compounds to screen for COVID-19).

Coveney outlined how CompBioMed worked with over 40 partners around the world to streamline the computational drug design pipeline. CompBioMed gained access to a wide range of supercomputers, from SuperMUC-NG (the most powerful supercomputer in the EU) to Piz Daint, Archer, Summit, Frontera, Theta and more. The researchers used a piece of middleware called Radical Cybertools to run workflows across a large number of nodes on multiple machines.

With computing power in hand, CompBioMed focused on how to ensure “validation, verification and uncertainty quantification” (or “VVUQ”) in the pipeline. “This is designed in general to raise confidence in HPC simulation,” Coveney said.

To effectively leverage the computing power and ensure “VVUQ,” CompBioMed combined machine learning with molecular dynamics. Machine learning was used first to whittle down the near-infinite list of candidate molecules. “We have to do searches in a hurry,” Coveney said. “We want to use computationally very fast methods that are also cheap … to search huge libraries of molecules, to explore chemical space, to predict new molecules and so on.” 

The ensemble molecular dynamics process. Image courtesy of Peter Coveney.

Then, with the list whittled down, CompBioMed used molecular dynamics simulations – 20 to 30 of them at a time. As Coveney explained, a single molecular dynamics simulation could have a large number of errors. “But if you run many of them concurrently … we can run those on very large supercomputers all at the same time,” Coveney said. “Then we can make reliable predictions that get fed back to another stage of the machine learning.”

The best candidate compounds from this process are then submitted to medical research labs for further testing. “We are already discovering many tens to hundreds of potential compounds that can be investigated by our experimental colleagues,” Coveney said. “And indeed, that’s happening already.”

“We’re trying to change the way medicine is actually understood and applied,” Coveney concluded. “We want to make the subject more amenable to scientific investigation, that it should revolve around theory, modeling and simulation in addition to experimental research.”

Rick Stevens dives into the COVID-19 HPC Consortium and machine learning-enabled research

Rick Stevens

Finally, Stevens took the virtual stage. Stevens – associate laboratory director at Argonne National Laboratory – has been working closely with the COVID-19 HPC Consortium, a public-private effort to pool supercomputing resources for COVID-19 research. Currently, the effort has over 40 members, comprising some 483 petaflops of resources, 50,000 GPUs, 136,000 nodes and five million CPU cores. 

As Stevens explained, the projects being tackled by the consortium fall into three broad categories: first, basic science, including things like analyzing the virus’ structure, protein functions and virus evolution; second, therapeutics (“the largest group”), aiming to discovery drug targets on the virus, design drugs and discover repurposable drugs; and finally, patient care – “things more related to optimizing the healthcare system or epidemiology.”

Stevens outlined some of the key work, especially where it intersected with Argonne. “If you’re gonna work on this problem, you need to understand the enemy,” Stevens said, describing how Argonne has used its Advanced Photon Source (APS) to identify new structures of COVID-19, which in turn produce new drug targets for simulations to examine. 

Like Coveney, Stevens highlighted the intersections of AI and supercomputing as viable pathways for processing massive amounts of compounds in a relatively short time frame. For instance, he said, researchers were using AI to reconcile models of proteins from various sources to produce even more accurate models. In the spring, Argonne also began assembling a large database – around 60 TB – containing descriptors, images and more for over four billion compounds, with the aim of producing massive datasets for machine learning applications.

“One of the strategies that we have is to use a combination of high-throughput virtual docking … to generate scores – generate them on thousands or millions of data points,” Stevens said, “but then use that data to train machine learning models and do inference on a much larger scale.” As in Coveney’s research, the most promising hits are then sent for wet lab screening. 

Argonne’s pipeline for COVID-19 drug discovery. Image courtesy of Rick Stevens.

Stevens also discussed the use of machine learning to understand the “trajectories” of molecular dynamics simulations and the use of reinforcement learning to essentially build drug molecules from the ground up, adding to them iteratively to improve the docking score.

“One of the overall challenges here, of course, is that there’s over 10⁶⁰ possible drugs,” Steven said, “and you can only test at the end of the day, in humans, a small fraction of these.” But now, with AI and supercomputing converging to create a new model of rapid drug design, that might be enough.

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

Nvidia-Arm Deal a Boon for RISC-V?

October 26, 2020

The $40 billion blockbuster acquisition deal that will bring chip maker Arm into the Nvidia corporate family could provide a boost for the competing RISC-V architecture. As regulators in the U.S., China and the Europe Read more…

By George Leopold

OpenHPC Progress Report – v2.0, More Recipes, Cloud and Arm Support, Says Schulz

October 26, 2020

Launched in late 2015 and transitioned to a Linux Foundation Project in 2016, OpenHPC has marched quietly but steadily forward. Its goal “to provide a reference collection of open-source HPC software components and bes Read more…

By John Russell

NASA Uses Supercomputing to Measure Carbon in the World’s Trees

October 22, 2020

Trees constitute one of the world’s most important carbon sinks, pulling enormous amounts of carbon dioxide from the atmosphere and storing the carbon in their trunks and the surrounding soil. Measuring this carbon sto Read more…

By Oliver Peckham

Nvidia Dominates (Again) Latest MLPerf Inference Results

October 22, 2020

The two-year-old AI benchmarking group MLPerf.org released its second set of inferencing results yesterday and again, as in the most recent MLPerf training results (July 2020), it was almost entirely The Nvidia Show, a p Read more…

By John Russell

With Optane Gaining, Intel Exits NAND Flash

October 21, 2020

In a sign that its 3D XPoint memory technology is gaining traction, Intel Corp. is departing the NAND flash memory and storage market with the sale of its manufacturing base in China to SK Hynix of South Korea. The $9 Read more…

By George Leopold

AWS Solution Channel

Live Webinar: AWS & Intel Research Webinar Series – Fast scaling research workloads on the cloud

Date: 27 Oct – 5 Nov

Join us for the AWS and Intel Research Webinar series.

You will learn how we help researchers process complex workloads, quickly analyze massive data pipelines, store petabytes of data, and advance research using transformative technologies. Read more…

Intel® HPC + AI Pavilion

Berlin Institute of Health: Putting HPC to Work for the World

Researchers from the Center for Digital Health at the Berlin Institute of Health (BIH) are using science to understand the pathophysiology of COVID-19, which can help to inform the development of targeted treatments. Read more…

HPE, AMD and EuroHPC Partner for Pre-Exascale LUMI Supercomputer

October 21, 2020

Not even a week after Nvidia announced that it would be providing hardware for the first four of the eight planned EuroHPC systems, HPE and AMD are announcing another major EuroHPC design win. Finnish supercomputing cent Read more…

By Oliver Peckham

OpenHPC Progress Report – v2.0, More Recipes, Cloud and Arm Support, Says Schulz

October 26, 2020

Launched in late 2015 and transitioned to a Linux Foundation Project in 2016, OpenHPC has marched quietly but steadily forward. Its goal “to provide a referen Read more…

By John Russell

Nvidia Dominates (Again) Latest MLPerf Inference Results

October 22, 2020

The two-year-old AI benchmarking group MLPerf.org released its second set of inferencing results yesterday and again, as in the most recent MLPerf training resu Read more…

By John Russell

HPE, AMD and EuroHPC Partner for Pre-Exascale LUMI Supercomputer

October 21, 2020

Not even a week after Nvidia announced that it would be providing hardware for the first four of the eight planned EuroHPC systems, HPE and AMD are announcing a Read more…

By Oliver Peckham

HPE to Build Australia’s Most Powerful Supercomputer for Pawsey

October 20, 2020

The Pawsey Supercomputing Centre in Perth, Western Australia, has had a busy year. Pawsey typically spends much of its time looking to the stars, working with a Read more…

By Oliver Peckham

DDN-Tintri Showcases Technology Integration with Two New Products

October 20, 2020

DDN, a long-time leader in HPC storage, announced two new products today and provided more detail around its strategy for integrating DDN HPC technologies with Read more…

By John Russell

Is the Nvidia A100 GPU Performance Worth a Hardware Upgrade?

October 16, 2020

Over the last decade, accelerators have seen an increasing rate of adoption in high-performance computing (HPC) platforms, and in the June 2020 Top500 list, eig Read more…

By Hartwig Anzt, Ahmad Abdelfattah and Jack Dongarra

Nvidia and EuroHPC Team for Four Supercomputers, Including Massive ‘Leonardo’ System

October 15, 2020

The EuroHPC Joint Undertaking (JU) serves as Europe’s concerted supercomputing play, currently comprising 32 member states and billions of euros in funding. I Read more…

By Oliver Peckham

ROI: Is HPC Worth It? What Can We Actually Measure?

October 15, 2020

HPC enables innovation and discovery. We all seem to agree on that. Is there a good way to quantify how much that’s worth? Thanks to a sponsored white pape Read more…

By Addison Snell, Intersect360 Research

Supercomputer-Powered Research Uncovers Signs of ‘Bradykinin Storm’ That May Explain COVID-19 Symptoms

July 28, 2020

Doctors and medical researchers have struggled to pinpoint – let alone explain – the deluge of symptoms induced by COVID-19 infections in patients, and what Read more…

By Oliver Peckham

Nvidia Said to Be Close on Arm Deal

August 3, 2020

GPU leader Nvidia Corp. is in talks to buy U.K. chip designer Arm from parent company Softbank, according to several reports over the weekend. If consummated Read more…

By George Leopold

Intel’s 7nm Slip Raises Questions About Ponte Vecchio GPU, Aurora Supercomputer

July 30, 2020

During its second-quarter earnings call, Intel announced a one-year delay of its 7nm process technology, which it says it will create an approximate six-month shift for its CPU product timing relative to prior expectations. The primary issue is a defect mode in the 7nm process that resulted in yield degradation... Read more…

By Tiffany Trader

Google Hires Longtime Intel Exec Bill Magro to Lead HPC Strategy

September 18, 2020

In a sign of the times, another prominent HPCer has made a move to a hyperscaler. Longtime Intel executive Bill Magro joined Google as chief technologist for hi Read more…

By Tiffany Trader

HPE Keeps Cray Brand Promise, Reveals HPE Cray Supercomputing Line

August 4, 2020

The HPC community, ever-affectionate toward Cray and its eponymous founder, can breathe a (virtual) sigh of relief. The Cray brand will live on, encompassing th Read more…

By Tiffany Trader

10nm, 7nm, 5nm…. Should the Chip Nanometer Metric Be Replaced?

June 1, 2020

The biggest cool factor in server chips is the nanometer. AMD beating Intel to a CPU built on a 7nm process node* – with 5nm and 3nm on the way – has been i Read more…

By Doug Black

Aurora’s Troubles Move Frontier into Pole Exascale Position

October 1, 2020

Intel’s 7nm node delay has raised questions about the status of the Aurora supercomputer that was scheduled to be stood up at Argonne National Laboratory next year. Aurora was in the running to be the United States’ first exascale supercomputer although it was on a contemporaneous timeline with... Read more…

By Tiffany Trader

Is the Nvidia A100 GPU Performance Worth a Hardware Upgrade?

October 16, 2020

Over the last decade, accelerators have seen an increasing rate of adoption in high-performance computing (HPC) platforms, and in the June 2020 Top500 list, eig Read more…

By Hartwig Anzt, Ahmad Abdelfattah and Jack Dongarra

Leading Solution Providers

Contributors

European Commission Declares €8 Billion Investment in Supercomputing

September 18, 2020

Just under two years ago, the European Commission formalized the EuroHPC Joint Undertaking (JU): a concerted HPC effort (comprising 32 participating states at c Read more…

By Oliver Peckham

Nvidia and EuroHPC Team for Four Supercomputers, Including Massive ‘Leonardo’ System

October 15, 2020

The EuroHPC Joint Undertaking (JU) serves as Europe’s concerted supercomputing play, currently comprising 32 member states and billions of euros in funding. I Read more…

By Oliver Peckham

Google Cloud Debuts 16-GPU Ampere A100 Instances

July 7, 2020

On the heels of the Nvidia’s Ampere A100 GPU launch in May, Google Cloud is announcing alpha availability of the A100 “Accelerator Optimized” VM A2 instance family on Google Compute Engine. The instances are powered by the HGX A100 16-GPU platform, which combines two HGX A100 8-GPU baseboards using... Read more…

By Tiffany Trader

Microsoft Azure Adds A100 GPU Instances for ‘Supercomputer-Class AI’ in the Cloud

August 19, 2020

Microsoft Azure continues to infuse its cloud platform with HPC- and AI-directed technologies. Today the cloud services purveyor announced a new virtual machine Read more…

By Tiffany Trader

Oracle Cloud Infrastructure Powers Fugaku’s Storage, Scores IO500 Win

August 28, 2020

In June, RIKEN shook the supercomputing world with its Arm-based, Fujitsu-built juggernaut: Fugaku. The system, which weighs in at 415.5 Linpack petaflops, topp Read more…

By Oliver Peckham

DOD Orders Two AI-Focused Supercomputers from Liqid

August 24, 2020

The U.S. Department of Defense is making a big investment in data analytics and AI computing with the procurement of two HPC systems that will provide the High Read more…

By Tiffany Trader

HPE, AMD and EuroHPC Partner for Pre-Exascale LUMI Supercomputer

October 21, 2020

Not even a week after Nvidia announced that it would be providing hardware for the first four of the eight planned EuroHPC systems, HPE and AMD are announcing a Read more…

By Oliver Peckham

Oracle Cloud Deepens HPC Embrace with Launch of A100 Instances, Plans for Arm, More 

September 22, 2020

Oracle Cloud Infrastructure (OCI) continued its steady ramp-up of HPC capabilities today with a flurry of announcements. Topping the list is general availabilit Read more…

By John Russell

  • arrow
  • Click Here for More Headlines
  • arrow
Do NOT follow this link or you will be banned from the site!
Share This